Companies / aTyr Pharma
aTyr Pharma
United States
aTyr Pharma translates tRNA synthetase biology into new therapies for fibrosis and inflammation
aTyr Pharma, based in United States, has 1 investor on file, among them Sofinnova. Its site was last checked 10 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital |
In the news
2 headlines naming aTyr PharmaEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from Sofinnova
42 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (97%), Fintech (3%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get aTyr Pharma and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Sofinnova adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/atyrpharma.com/investors
# also
GET /v1/companies/atyrpharma.com
GET /v1/companies/atyrpharma.com/news